ReP USP - Resultado da busca

Artigo de periodico-carta/editorial
Autoantibodies against an immunodominant epitope from apolipoprotein B and risk of cardiovascular events in subjects with type 2 diabetes (2023)
Sant´Anna, Viviane Aparecida Rodrigues; Izar, Maria Cristina O. ; Fonseca, Henrique Andrade Rodrigues da ; Gidlund, Magnus Ake
Fonte: European Journal of Internal Medicine. Unidade: ICB
Assuntos: IMUNOLOGIA, AUTOANTICORPOS, APOLIPOPROTEÍNAS, EPITOPOS, DIABETES MELLITUS, DOENÇAS CARDIOVASCULARES, LIPOPROTEÍNAS LDL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANT´ANNA, Viviane Aparecida Rodrigues et al. Autoantibodies against an immunodominant epitope from apolipoprotein B and risk of cardiovascular events in subjects with type 2 diabetes. European Journal of Internal Medicine. Amsterdam: Elsevier BV. Disponível em: https://doi.org/10.1016/j.ejim.2023.07.018. Acesso em: 01 nov. 2024. , 2023
APA
Sant´Anna, V. A. R., Izar, M. C. O., Fonseca, H. A. R. da, & Gidlund, M. A. (2023). Autoantibodies against an immunodominant epitope from apolipoprotein B and risk of cardiovascular events in subjects with type 2 diabetes. European Journal of Internal Medicine. Amsterdam: Elsevier BV. doi:10.1016/j.ejim.2023.07.018
NLM
Sant´Anna VAR, Izar MCO, Fonseca HAR da, Gidlund MA. Autoantibodies against an immunodominant epitope from apolipoprotein B and risk of cardiovascular events in subjects with type 2 diabetes [Internet]. European Journal of Internal Medicine. 2023 ; 116 152-154.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1016/j.ejim.2023.07.018
Vancouver
Sant´Anna VAR, Izar MCO, Fonseca HAR da, Gidlund MA. Autoantibodies against an immunodominant epitope from apolipoprotein B and risk of cardiovascular events in subjects with type 2 diabetes [Internet]. European Journal of Internal Medicine. 2023 ; 116 152-154.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1016/j.ejim.2023.07.018
Artigo de periodico
Cross-sectional analysis reveals autoantibody signatures associated with COVID-19 severity (2023)
Baiocchi, Gabriela Crispim ; Vojdani, Aristo ; Rosenberg, Avi Z. ; Vojdani, Elroy ; Halpert, Gilad ; Yuri Ostrinski ; Israel Zyskind ; Filgueiras, Igor Salerno ; Schimke, Lena Friederike ; Marques, Alexandre Henrique Carvalho ; Giil, Lasse M. ; Lavi, Yael Bublil ; Silverberg, Jonathan I. ; Zimmerman, Jason; Hill, Dana Ashley ; Thornton, Amanda ; Kim, Myungjin; Vito, Roberta De ; Fonseca, Dennyson Leandro Mathias da ; Plaça, Desireé Rodrigues ; Freire, Paula Paccielli ; Carmen Scheibenbogen ; Heidecke, Harald; Lattin, Miriam T.; Ochs, Hans D. ; Gabriela Riemekasten ; Howard Amital ; Yehuda Shoenfeld ; Câmara, Niels Olsen Saraiva ; Calich, Vera Lúcia Garcia ; Marques, Otavio Cabral
Fonte: Journal of Medical Virology. Unidades: ICB, FCF
Assuntos: IMUNOLOGIA, COVID-19, INFECÇÕES POR CORONAVIRUS, INFECÇÕES POR VÍRUS DE RNA, DOENÇAS AUTOIMUNES, AUTOANTICORPOS, IMUNOPROTEÍNAS, CITOCINAS, QUIMIOCINAS, IMUNOGLOBULINAS, ESTUDOS TRANSVERSAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BAIOCCHI, Gabriela Crispim et al. Cross-sectional analysis reveals autoantibody signatures associated with COVID-19 severity. Journal of Medical Virology, v. 95, n. 1, p. 1-13, 2023Tradução . . Disponível em: https://doi.org/10.1002/jmv.28538. Acesso em: 01 nov. 2024.
APA
Baiocchi, G. C., Vojdani, A., Rosenberg, A. Z., Vojdani, E., Halpert, G., Yuri Ostrinski,, et al. (2023). Cross-sectional analysis reveals autoantibody signatures associated with COVID-19 severity. Journal of Medical Virology, 95( 1), 1-13. doi:10.1002/jmv.28538
NLM
Baiocchi GC, Vojdani A, Rosenberg AZ, Vojdani E, Halpert G, Yuri Ostrinski, Israel Zyskind, Filgueiras IS, Schimke LF, Marques AHC, Giil LM, Lavi YB, Silverberg JI, Zimmerman J, Hill DA, Thornton A, Kim M, Vito RD, Fonseca DLM da, Plaça DR, Freire PP, Carmen Scheibenbogen, Heidecke H, Lattin MT, Ochs HD, Gabriela Riemekasten, Howard Amital, Yehuda Shoenfeld, Câmara NOS, Calich VLG, Marques OC. Cross-sectional analysis reveals autoantibody signatures associated with COVID-19 severity [Internet]. Journal of Medical Virology. 2023 ; 95( 1): 1-13.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1002/jmv.28538
Vancouver
Baiocchi GC, Vojdani A, Rosenberg AZ, Vojdani E, Halpert G, Yuri Ostrinski, Israel Zyskind, Filgueiras IS, Schimke LF, Marques AHC, Giil LM, Lavi YB, Silverberg JI, Zimmerman J, Hill DA, Thornton A, Kim M, Vito RD, Fonseca DLM da, Plaça DR, Freire PP, Carmen Scheibenbogen, Heidecke H, Lattin MT, Ochs HD, Gabriela Riemekasten, Howard Amital, Yehuda Shoenfeld, Câmara NOS, Calich VLG, Marques OC. Cross-sectional analysis reveals autoantibody signatures associated with COVID-19 severity [Internet]. Journal of Medical Virology. 2023 ; 95( 1): 1-13.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1002/jmv.28538
Artigo de periodico
Positive Association between Autoantibodies Against Oxidized LDL and HDL-C: A Novel Mechanism for HDL Cardioprotection? (2022)
Nunez, Carla Evelyn Coimbra ; Oliveira, Joaquim Barreto ; Barros-Mazon, Sílvia de; Zago, Vanessa Helena de Souza; Kaplan, Denise Beheregaray; Nakamura, Ruy T; Gidlund, Magnus Ake ; Gomes, Erica I. L; Cazita, Patrícia Miralda ; Nakandakare, Edna Regina ; Carmo, Helison Rafael P; Sposito, Andrei C. ; Faria, Eliana Cotta de
Fonte: Arquivos brasileiros de cardiologia. Unidades: FM, ICB
Assuntos: LIPOPROTEÍNAS LDL, LIPOPROTEÍNAS HDL, AUTOANTICORPOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NUNEZ, Carla Evelyn Coimbra et al. Positive Association between Autoantibodies Against Oxidized LDL and HDL-C: A Novel Mechanism for HDL Cardioprotection?. Arquivos brasileiros de cardiologia, v. 119, n. 5, p. 714-721, 2022Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/53825. Acesso em: 01 nov. 2024.
APA
Nunez, C. E. C., Oliveira, J. B., Barros-Mazon, S. de, Zago, V. H. de S., Kaplan, D. B., Nakamura, R. T., et al. (2022). Positive Association between Autoantibodies Against Oxidized LDL and HDL-C: A Novel Mechanism for HDL Cardioprotection? Arquivos brasileiros de cardiologia, 119( 5), 714-721. doi:10.36660/abc.20210796
NLM
Nunez CEC, Oliveira JB, Barros-Mazon S de, Zago VH de S, Kaplan DB, Nakamura RT, Gidlund MA, Gomes EIL, Cazita PM, Nakandakare ER, Carmo HRP, Sposito AC, Faria EC de. Positive Association between Autoantibodies Against Oxidized LDL and HDL-C: A Novel Mechanism for HDL Cardioprotection? [Internet]. Arquivos brasileiros de cardiologia. 2022 ; 119( 5): 714-721.[citado 2024 nov. 01 ] Available from: https://observatorio.fm.usp.br/handle/OPI/53825
Vancouver
Nunez CEC, Oliveira JB, Barros-Mazon S de, Zago VH de S, Kaplan DB, Nakamura RT, Gidlund MA, Gomes EIL, Cazita PM, Nakandakare ER, Carmo HRP, Sposito AC, Faria EC de. Positive Association between Autoantibodies Against Oxidized LDL and HDL-C: A Novel Mechanism for HDL Cardioprotection? [Internet]. Arquivos brasileiros de cardiologia. 2022 ; 119( 5): 714-721.[citado 2024 nov. 01 ] Available from: https://observatorio.fm.usp.br/handle/OPI/53825

Unidades USP

ReP

Filtros

Autores

Autores USP

Assuntos

Afiliação dos autores externos não normalizada

País das instituições de afiliação dos autores externos